274 related articles for article (PubMed ID: 27900643)
1. First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosis.
Talaei-Khoei M; Riklin E; Merker VL; Sheridan MR; Jordan JT; Plotkin SR; Vranceanu AM
J Neurooncol; 2017 Jan; 131(2):413-419. PubMed ID: 27900643
[TBL] [Abstract][Full Text] [Related]
2. Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey.
Wolters PL; Ghriwati NA; Baker M; Martin S; Berg D; Erickson G; Franklin B; Merker VL; Oberlander B; Reeve S; Rohl C; Rosser T; Vranceanu AM
Clin Trials; 2024 Feb; 21(1):73-84. PubMed ID: 37962219
[TBL] [Abstract][Full Text] [Related]
3. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis.
Merker VL; Bredella MA; Cai W; Kassarjian A; Harris GJ; Muzikansky A; Nguyen R; Mautner VF; Plotkin SR
Am J Med Genet A; 2014 Jun; 164A(6):1431-7. PubMed ID: 24664633
[TBL] [Abstract][Full Text] [Related]
4. Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.
Wang DL; Smith KB; Esparza S; Leigh FA; Muzikansky A; Park ER; Plotkin SR
Genet Med; 2012 Dec; 14(12):977-82. PubMed ID: 22878510
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
[TBL] [Abstract][Full Text] [Related]
6. Current status and recommendations for biomarkers and biobanking in neurofibromatosis.
Hanemann CO; Blakeley JO; Nunes FP; Robertson K; Stemmer-Rachamimov A; Mautner V; Kurtz A; Ferguson M; Widemann BC; Evans DG; Ferner R; Carroll SL; Korf B; Wolkenstein P; Knight P; Plotkin SR;
Neurology; 2016 Aug; 87(7 Suppl 1):S40-8. PubMed ID: 27527649
[TBL] [Abstract][Full Text] [Related]
7. Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTT.
Merker VL; McDannold S; Riklin E; Talaei-Khoei M; Sheridan MR; Jordan JT; Plotkin SR; Vranceanu AM
J Neurooncol; 2018 Jan; 136(2):335-342. PubMed ID: 29119424
[TBL] [Abstract][Full Text] [Related]
8. Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.
Wolters PL; Vranceanu AM; Thompson HL; Martin S; Merker VL; Baldwin A; Barnett C; Koetsier KS; Hingtgen CM; Funes CJ; Tonsgard JH; Schorry EK; Allen T; Smith T; Franklin B; Reeve S;
Neurology; 2021 Aug; 97(7 Suppl 1):S50-S63. PubMed ID: 34230198
[TBL] [Abstract][Full Text] [Related]
9. PROMIS Pain Interference and Physical Function Scores Correlate With the Foot and Ankle Ability Measure (FAAM) in Patients With Hallux Valgus.
Nixon DC; McCormick JJ; Johnson JE; Klein SE
Clin Orthop Relat Res; 2017 Nov; 475(11):2775-2780. PubMed ID: 28836098
[TBL] [Abstract][Full Text] [Related]
10. 2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.
Fisher MJ; Belzberg AJ; de Blank P; De Raedt T; Elefteriou F; Ferner RE; Giovannini M; Harris GJ; Kalamarides M; Karajannis MA; Kim A; Lázaro C; Le LQ; Li W; Listernick R; Martin S; Morrison H; Pasmant E; Ratner N; Schorry E; Ullrich NJ; Viskochil D; Weiss B; Widemann BC; Zhu Y; Bakker A; Serra E
Am J Med Genet A; 2018 May; 176(5):1258-1269. PubMed ID: 29681099
[TBL] [Abstract][Full Text] [Related]
11. Genetic Counseling for Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis-Practice Resource of the National Society of Genetic Counselors.
Radtke HB; Bergner AL; Goetsch AL; McGowan C; Panzer K; Cannon A
J Genet Couns; 2020 Oct; 29(5):692-714. PubMed ID: 32602153
[TBL] [Abstract][Full Text] [Related]
12. Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis.
Merker VL; Dai A; Radtke HB; Knight P; Jordan JT; Plotkin SR
BMC Health Serv Res; 2018 Aug; 18(1):668. PubMed ID: 30157837
[TBL] [Abstract][Full Text] [Related]
13. Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use.
Bettegowda C; Upadhayaya M; Evans DG; Kim A; Mathios D; Hanemann CO;
Neurology; 2021 Aug; 97(7 Suppl 1):S91-S98. PubMed ID: 34230207
[TBL] [Abstract][Full Text] [Related]
14. From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis.
Ferner RE; Bakker A; Elgersma Y; Evans DGR; Giovannini M; Legius E; Lloyd A; Messiaen LM; Plotkin S; Reilly KM; Schindeler A; Smith MJ; Ullrich NJ; Widemann B; Sherman LS
Am J Med Genet A; 2019 Jun; 179(6):1098-1106. PubMed ID: 30908866
[TBL] [Abstract][Full Text] [Related]
15. First report of factors associated with satisfaction in patients with neurofibromatosis.
Riklin E; Talaei-Khoei M; Merker VL; Sheridan MR; Jordan JT; Plotkin SR; Vranceanu AM
Am J Med Genet A; 2017 Mar; 173(3):671-677. PubMed ID: 28211981
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis type 2 (NF 2) or schwannomatosis?--Case report study and diagnostic criteria.
Radek M; Tomasik B; Wojdyn M; Snopkowska-Wiaderna D; Błaszczyk M; Radek A
Neurol Neurochir Pol; 2016; 50(3):219-25. PubMed ID: 27154453
[TBL] [Abstract][Full Text] [Related]
17. Patient-Reported Outcomes Measurement Information System (PROMIS) instruments among individuals with symptomatic knee osteoarthritis: a cross-sectional study of floor/ceiling effects and construct validity.
Driban JB; Morgan N; Price LL; Cook KF; Wang C
BMC Musculoskelet Disord; 2015 Sep; 16():253. PubMed ID: 26369412
[TBL] [Abstract][Full Text] [Related]
18. Association of Physical Function, Anxiety, and Pain Interference in Nonshoulder Upper Extremity Patients Using the PROMIS Platform.
Kazmers NH; Hung M; Rane AA; Bounsanga J; Weng C; Tyser AR
J Hand Surg Am; 2017 Oct; 42(10):781-787. PubMed ID: 28890332
[TBL] [Abstract][Full Text] [Related]
19. The influence of mental health on Patient-Reported Outcomes Measurement Information System (PROMIS) and traditional outcome instruments in patients with symptomatic glenohumeral arthritis.
Kohan EM; Hill JR; Schwabe M; Aleem AW; Keener JD; Chamberlain AM
J Shoulder Elbow Surg; 2019 Feb; 28(2):e40-e48. PubMed ID: 30552069
[TBL] [Abstract][Full Text] [Related]
20. Floor Effect of PROMIS Depression CAT Associated With Hasty Completion in Orthopaedic Surgery Patients.
Guattery JM; Dardas AZ; Kelly M; Chamberlain A; McAndrew C; Calfee RP
Clin Orthop Relat Res; 2018 Apr; 476(4):696-703. PubMed ID: 29419628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
